Neurological organoid company System1 raises $25M in series A

System1 Biosciences Inc. (San Francisco, Calif.) raised $25 million in a series A round co-led by CRV and Pfizer Ventures. Alexandria Venture Investments, Dolby Family Ventures, Longevity Fund, Riot Ventures, Kinled Holding, Wilmot Ventures, Webb Investment Network, Liquid 2 Ventures and Boom Capital also participated.

System1 is developing a phenotypic screening platform to discover drugs to treat epilepsy, autism and schizophrenia...